Press Releases

mdgroup Listed Among the UK’s Fastest-Scaling Firms in Organic Growth 25 Index

Bracknell, UK – 14th February 2022: mdgroup, a leading global medtech and patient health services company pioneering a patient-first approach to clinical research, has been named as one of the UK's fastest-scaling businesses in 2021's Organic Growth 25 (OG25) index in recognition of its major growth and success, without significant external investment.

Passive or Active? Supply chain leaders compare key pharmaceutical cold chain technologies in latest white paper

For Tower sales enquiries please contact: Nick Gilmore, Global Head of Sales & Marketing Email: Nick.Gilmore@towercoldchain.com For Tower media enquiries please contact: Simon Wildash or Rhiannon Hopper, Nielsen McAllister Tel: +44 (0)1332 293939 Email: tower@nmpr.co.uk

mdgroup Appoints Steph Katz as Director of Seacole Health

mdgroup Appoints Steph Katz as Director of Seacole Health Combining Passion for Nursing and Clinical Research to Provide Remarkable Patient Experiences Bracknell, UK: 15 February 2022 - mdgroup, the leading global provider of personalised clinical study services, has appointed Steph Katz as Director of business subsidiary Seacole Health. Seacole Health brings mdgroup’s mobile health and clinical research staff resourcing under one roof. Steph is the ideal person to lead this exciting new venture because of her wealth of healthcare knowledge. Having started as an oncology nurse in intensive care units, Steph achieved her MSN in Nursing Education and began training research coordinators, clinical nurses and fellows. She then took on a management role, helping to develop and operationalize institutional, federal and commercial clinical research projects before pursuing an MBA.

Curebase Adds Two Clinical Trial Veterans to Kick-off New Advisory Board

Curebase, a company committed to democratizing access to clinical studies, has named Dr. Aaron Kamauu and Dr. Amir Lahav to the Curebase Advisory Board.

Tesis Biosciences Acquires Genome Explorations to Accelerate Clinical Research and Product Development for Chronic Disease Cures

Tesis Biosciences Acquires Genome Explorations to Accelerate Clinical Research and Product Development for Chronic Disease Cures

QUOTIENT SCIENCES COMPLETES INTEGRATION OF DRUG SUBSTANCE INTO TRANSLATIONAL PHARMACEUTICS® PLATFORM

AES Clean Technology Accelerates Cleanroom Capabilities with $14.2 million Investment

Abzena appoints Kevin Lundquist as Chief Financial Officer

InsightRX Reports Record Growth in Platform Adoption by Health Systems and Biopharma Companies

Precision dosing intelligence company tripled client base, expanded oncology focus, and developed new drug models in 2021

MetaboParis-Santé platform first in France to install Bruker In Vitro Diagnostic research by NMR* system at Université de Paris.

Université de Paris has installed new Bruker In Vitro Diagnostic research (IVDr) nuclear magnetic resonance (NMR) spectrometer within its MetaboParis-Santé platform located in the center of Paris city, France.

Germfree Launches Novel Mobile Cleanroom Technology for Advanced Therapies

Germfree has announced a first of its kind, mobile platform for cell and gene (CGT) therapy.

Saama Appoints Scott Rogers as Company’s Chief Financial Officer

Veteran finance executive Scott Rogers appointed Saama CFO following recent $430 million dollar growth investment announcement

mdgroup Newly Appointed Medical Director Dr Arthur Lazarus Addresses Remote Patient Healthcare Selection at SCOPE 2022

‘Double Agent’ in Healthcare Industry Will Promote a Truly Patient-Centric Agenda Bracknell, UK - 3 February 2022 - mdgroup, the leading global provider of personalised clinical study services, has appointed Dr Arthur Lazarus as Medical Director. Dr Lazarus will also be speaking at SCOPE 2022 on Thursday 10th February,11.30am ET, discussing how proper selection of healthcare providers for remote patient visits improves data integrity and monitoring. He will be sharing how the latest medical technologies meet patient care to create remarkable patient experiences, and the important factors to consider when selecting Healthcare Professionals for mobile health patient visits.

See How the New ClinOne Connects, Informs and Empowers Patients in Complex Clinical Trials at the SCOPE Summit for Clinical Ops Execs

At the SCOPE Summit (Feb 7-10, 2022), ClinOne will unveil its new brand, product marketecture, and messaging – and showcase how its mission to connect, inform and empower clinical trials patients is making it one of the fastest growing companies to watch in clinical technology.

DFE Pharma appoints Martti Hedman as new CEO

DFE Pharma appoints Martti Hedman as new CEO The combination of his experience, culture and drive makes him an ideal fit for DFE Pharma for the next stages of growth Goch, Germany (7th February 2022) – DFE Pharma, a global leader in pharma- and nutraceutical excipient solutions, today announced that Martti Hedman has been appointed as the new Chief Executive Officer. An experienced business leader, Hedman will succeed Bas van Driel and assume responsibilities on 14th February. Van Driel decided to step down in order to allow the company to further grow after setting the company up for success.

Rho Clinical Development Expert Available for One-on-one Discussions at the 14th Annual Outsourcing in Clinical Trials West Coast

Rho, a full-service contract research organization (CRO), is sharing its clinical development expertise with attendees of the 14th Annual Outsourcing in Clinical Trials (OCT) West Coast conference, taking place at the Hyatt Regency San Francisco Airport from February 15-16, 2022. Rho’s Associate Director of Business Development Brennan Munley is offering one-on-one meetings with those interested in learning more about how Rho can help ensure an efficient and a successful drug development process.

PharmiWeb Launches New US-Focused Life Science Job Board

A new Life Science and Clinical Research Job Board in the USA.

Curebase Joins the SCRS Global Impact Partner Program

Curebase Joins the SCRS Global Impact Partner Program

CD Formulation Provides Tailor-made Solutions for Thickener Excipients for Drug Development

A Triplet Breakthrough for Novel Concepts Medical: Stopped COVID-19, the Omicron Variant, and Long COVID-19 Symptoms, Including Memory Loss

Novel Concepts Medical announces another major breakthrough in its research of COVID-19.